المؤلفون: Ruotsalainen, Janne, Lopez‐Ramos, Dorys, Rogava, Meri, Shridhar, Naveen, Glodde, Nicole, Gaffal, Evelyn, Hölzel, Michael, Bald, Tobias, Tüting, Thomas

المصدر: Clinical & Translational Immunology; 2021, Vol. 10 Issue 4, p1-14, 14p

مصطلحات موضوعية: MELANOMA, CANCER treatment, TYPE I interferons, IMMUNITY, TREATMENT effectiveness, T cells

المؤلفون: Ho, Patricia^1,2 (AUTHOR), Melms, Johannes C.^1,2 (AUTHOR), Rogava, Meri^1,2 (AUTHOR), Frangieh, Chris J.^3,4 (AUTHOR), Poźniak, Joanna^5,6 (AUTHOR), Shah, Shivem B.^1,2 (AUTHOR), Walsh, Zachary^1,2 (AUTHOR), Kyrysyuk, Oleksandr⁷ (AUTHOR), Amin, Amit Dipak^1,2 (AUTHOR), Caprio, Lindsay^1,2 (AUTHOR), Fullerton, Benjamin T.¹ (AUTHOR), Soni, Rajesh Kumar⁸ (AUTHOR), Ager, Casey R.^1,2 (AUTHOR), Biermann, Jana^1,2,9 (AUTHOR), Wang, Yiping^1,2,9 (AUTHOR), Khosravi-Maharlooei, Mohsen^2,10 (AUTHOR), Zanetti, Giorgia² (AUTHOR), Mu, Michael^1,2 (AUTHOR), Fatima, Hijab¹¹ (AUTHOR), Moore, Emily K.^2,12 (AUTHOR)

المصدر: Cancer Cell. Jul2023, Vol. 41 Issue 7, p1207-1207. 1p.

مصطلحات موضوعية: *PROGRAMMED cell death 1 receptors, *PROGRAMMED death-ligand 1, *IMMUNE checkpoint proteins, *IMMUNITY, *PROTEIN stability, *T cells